Related Experiment Videos
Hemorrhagic cystitis in bone marrow transplantation
1Department of Urology, Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, North Carolina.
Urology
|September 1, 1994
Summary
Hemorrhagic cystitis is a serious risk for bone marrow transplant patients, particularly younger individuals and those receiving allogeneic transplants. This complication significantly increases costs, hospitalization, and mortality, impacting patient survival.
Area of Science:
- Hematology
- Oncology
- Urology
Background:
- Bone marrow transplantation (BMT) patients face risks of hemorrhagic cystitis (HC) despite preventative strategies.
- HC can negatively affect patient survival and other critical outcomes.
Purpose of the Study:
- To identify risk factors for hemorrhagic cystitis in BMT recipients.
- To evaluate the impact of HC on patient outcomes, including survival and healthcare costs.
Main Methods:
- Retrospective study of patients who underwent bone marrow transplantation.
- Analysis of risk factors and outcome variables associated with hemorrhagic cystitis.
Main Results:
- Hemorrhagic cystitis was more prevalent in younger patients and those undergoing allogeneic transplantation.
- HC correlated with increased hospital costs, prolonged hospitalization, and higher mortality rates.
- Factors like gender, race, malignancy type, comorbidities, and other complications did not show association with HC occurrence.
Conclusions:
- Hemorrhagic cystitis is a significant complication of BMT, affecting both survival and economic outcomes.
- Increasing BMT rates necessitate urologist preparedness for managing HC.
- Early recognition and management are crucial for improving BMT patient outcomes.